Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Wandl

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Versicherungsmedizin|July 1, 2004
[Health risks of smoking--up to now, clearly underestimated]U Wandl, M Fessel
Versicherungsmedizin|January 6, 2006
[New findings on the influence of body weight on mortality]U Wandl, Ch Jaggy
Versicherungsmedizin|January 12, 2000
[ReIntra--a model for rehabilitation of severely injured accident victims]S Hinterstrasser-Irmer, U Wandl
International Journal of Cell Cloning|September 1, 1989
Rapid decline of clonogenic hemopoietic progenitors in semisolid cultures of bone marrow samples derived from patients with chronic myeloid leukemiaU Wandl, H A Messner
Therapeutische Umschau. Revue Therapeutique|November 9, 2007
[Back to work--how can this be achieved?]R Meek, Ch Maurer, U Wandl
Versicherungsmedizin|April 12, 2007
[Extent to which a claimant's loss-mitigation and cooperation obligations towards the insurer are enforceable--requirements for an expert medical opinion]C Stadtland, S Seidelmann, U Wandl
Versicherungsmedizin|August 10, 2013
[Health-related quality of life of people with severe traumatic injury: a longitudinal study using the SF-36 health survey]J Bauer, B Beck, U Wandl
Onkologie|January 1, 1988
[The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia]O Kloke, D May, U Wandl, et al.
Journal of Cellular Physiology|August 1, 1988
Segregation of precursors with high proliferative potential from their differentiated progeny in a myeloma cell lineU Wandl, T Hoang, M Minden, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alphaC Doberauer, B Mengelkoch, O Kloke, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Versicherungsmedizin|July 1, 2004
[Health risks of smoking--up to now, clearly underestimated]U Wandl, M Fessel
Versicherungsmedizin|January 6, 2006
[New findings on the influence of body weight on mortality]U Wandl, Ch Jaggy
Versicherungsmedizin|January 12, 2000
[ReIntra--a model for rehabilitation of severely injured accident victims]S Hinterstrasser-Irmer, U Wandl
International Journal of Cell Cloning|September 1, 1989
Rapid decline of clonogenic hemopoietic progenitors in semisolid cultures of bone marrow samples derived from patients with chronic myeloid leukemiaU Wandl, H A Messner
Therapeutische Umschau. Revue Therapeutique|November 9, 2007
[Back to work--how can this be achieved?]R Meek, Ch Maurer, U Wandl
Versicherungsmedizin|April 12, 2007
[Extent to which a claimant's loss-mitigation and cooperation obligations towards the insurer are enforceable--requirements for an expert medical opinion]C Stadtland, S Seidelmann, U Wandl
Versicherungsmedizin|August 10, 2013
[Health-related quality of life of people with severe traumatic injury: a longitudinal study using the SF-36 health survey]J Bauer, B Beck, U Wandl
Onkologie|January 1, 1988
[The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia]O Kloke, D May, U Wandl, et al.
Journal of Cellular Physiology|August 1, 1988
Segregation of precursors with high proliferative potential from their differentiated progeny in a myeloma cell lineU Wandl, T Hoang, M Minden, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1991
Treatment of metastatic carcinoid tumors and the carcinoid syndrome with recombinant interferon alphaC Doberauer, B Mengelkoch, O Kloke, et al.
Pageof 3